Jeffrey Robert Ajer Biomarin Pharmaceutical Inc (BMRN) insider trading activity

Jeffrey Robert Ajer is EVP, Chief Commercial Officer of BIOMARIN PHARMACEUTICAL INC. Currently has a direct ownership of 66,767 shares of BMRN, which is worth approximately $4.69 Million. The most recent transaction as insider was on Mar 15, 2022, when has been sold 11,940 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 66.8K

0% 3M change

9.81% 12M change

Total Value Held $4.69 Million

Jeffrey Robert Ajer Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 15 2022	BUY Grant, award, or other acquisition	-	11,940 Added 13.4%	77,163 Common Stock
Mar 08 2022	BUY Grant, award, or other acquisition	-	9,370 Added 12.56%	65,223 Common Stock
Oct 26 2021	SELL Open market or private sale	$201,590 $73.6 p/Share	2,739 Reduced 4.67%	55,853 Common Stock
Apr 30 2021	BUY Grant, award, or other acquisition	$21,344 $62.41 p/Share	342 Added 0.58%	58,592 Common Stock
Apr 08 2021	SELL Open market or private sale	$121,131 $78.81 p/Share	1,537 Reduced 2.57%	58,250 Common Stock
Mar 30 2021	SELL Open market or private sale	$123,553 $74.79 p/Share	1,652 Reduced 2.69%	59,787 Common Stock
Mar 24 2021	SELL Open market or private sale	$90,110 $76.3 p/Share	1,181 Reduced 1.89%	61,439 Common Stock
Mar 22 2021	SELL Payment of exercise price or tax liability	$118,801 $78.52 p/Share	1,513 Reduced 2.36%	62,620 Common Stock
Mar 18 2021	SELL Open market or private sale	$102,011 $77.99 p/Share	1,308 Reduced 2.0%	64,133 Common Stock
Mar 16 2021	SELL Payment of exercise price or tax liability	$99,369 $77.21 p/Share	1,287 Reduced 1.93%	65,441 Common Stock
Mar 15 2021	SELL Payment of exercise price or tax liability	$413,350 $78.39 p/Share	5,273 Reduced 7.32%	66,728 Common Stock
Mar 15 2021	BUY Grant, award, or other acquisition	-	10,720 Added 12.96%	72,001 Common Stock
Oct 14 2020	SELL Open market or private sale	$169,489 $79.91 p/Share	2,121 Reduced 3.35%	61,281 Common Stock

Also insider at

NKTR

NEKTAR THERAPEUTICS Healthcare

Director

JRA